Home
About
Overview
Sharing Data
ORCID
Help
History (17)
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials.
Synthetic Lethal Mutations
Hepatobiliary Elimination
Estimating the impact of the COVID-19 pandemic on out-of-hospital cardiac arrest burden of disease in the United States.
Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans.
See All 17 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans.
Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans. Cancer Res Commun. 2023 11 08; 3(11):2256-2267.
View in:
PubMed
subject areas
Autoantibodies
Humans
Immunoglobulin G
Long Interspersed Nucleotide Elements
Neoplasms
Retroelements
authors with profiles
Takemasa Tsuji
Junko Matsuzaki